Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Guglielmetti

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Review of Neurotherapeutics|November 19, 2019
Approaching the appropriate pharmacotherapy of menstrual migrainePaolo Martelletti, Martina Guglielmetti
International Journal of Environmental Research and Public Health|June 11, 2020
The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible DifferencesMartina Guglielmetti, Gianluca Serafini, Mario Amore, et al.
Expert Opinion on Emerging Drugs|November 29, 2018
Emerging drugs for migraine treatment: an updateGiorgio Lambru, Anna P Andreou, Martina Guglielmetti, et al.
Pharmacogenomics|October 23, 2019
The future of pharmacogenetics in the treatment of migraineMarina Borro, Martina Guglielmetti, Maurizio Simmaco, et al.
Internal and Emergency Medicine|January 2, 2020
Acute headache management in emergency department. A narrative reviewMaria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Expert Review of Neurotherapeutics|May 22, 2020
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectivesEleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, et al.
The Journal of Headache and Pain|May 19, 2019
Optimising migraine treatment: from drug-drug interactions to personalized medicineLeda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, et al.
The Journal of Headache and Pain|January 1, 2020
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache CentreAndrea Negro, Paolo Sciattella, Daniele Rossi, et al.
Cephalalgia : an International Journal of Headache|December 17, 2019
The clinical and public health implications and risks of widening the definition of chronic migraineMartina Guglielmetti, Alberto Raggi, Raffaele Ornello, et al.
Expert Review of Clinical Pharmacology|June 22, 2019
Fremanezumab for the preventive treatment of migraine in adultsLuana Lionetto, Martina Curto, Giusy Ylenia Cisale, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Review of Neurotherapeutics|November 19, 2019
Approaching the appropriate pharmacotherapy of menstrual migrainePaolo Martelletti, Martina Guglielmetti
International Journal of Environmental Research and Public Health|June 11, 2020
The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible DifferencesMartina Guglielmetti, Gianluca Serafini, Mario Amore, et al.
Expert Opinion on Emerging Drugs|November 29, 2018
Emerging drugs for migraine treatment: an updateGiorgio Lambru, Anna P Andreou, Martina Guglielmetti, et al.
Pharmacogenomics|October 23, 2019
The future of pharmacogenetics in the treatment of migraineMarina Borro, Martina Guglielmetti, Maurizio Simmaco, et al.
Internal and Emergency Medicine|January 2, 2020
Acute headache management in emergency department. A narrative reviewMaria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Expert Review of Neurotherapeutics|May 22, 2020
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectivesEleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, et al.
The Journal of Headache and Pain|May 19, 2019
Optimising migraine treatment: from drug-drug interactions to personalized medicineLeda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, et al.
The Journal of Headache and Pain|January 1, 2020
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache CentreAndrea Negro, Paolo Sciattella, Daniele Rossi, et al.
Cephalalgia : an International Journal of Headache|December 17, 2019
The clinical and public health implications and risks of widening the definition of chronic migraineMartina Guglielmetti, Alberto Raggi, Raffaele Ornello, et al.
Expert Review of Clinical Pharmacology|June 22, 2019
Fremanezumab for the preventive treatment of migraine in adultsLuana Lionetto, Martina Curto, Giusy Ylenia Cisale, et al.
Pageof 2